JP3788689B2 - Livestock health promotion methods - Google Patents

Livestock health promotion methods Download PDF

Info

Publication number
JP3788689B2
JP3788689B2 JP22827998A JP22827998A JP3788689B2 JP 3788689 B2 JP3788689 B2 JP 3788689B2 JP 22827998 A JP22827998 A JP 22827998A JP 22827998 A JP22827998 A JP 22827998A JP 3788689 B2 JP3788689 B2 JP 3788689B2
Authority
JP
Japan
Prior art keywords
magnesium chloride
calf
livestock
health promotion
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP22827998A
Other languages
Japanese (ja)
Other versions
JP2000063285A (en
Inventor
功夫 森屋
Original Assignee
功夫 森屋
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 功夫 森屋 filed Critical 功夫 森屋
Priority to JP22827998A priority Critical patent/JP3788689B2/en
Publication of JP2000063285A publication Critical patent/JP2000063285A/en
Application granted granted Critical
Publication of JP3788689B2 publication Critical patent/JP3788689B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【0001】
【産業上の利用分野】
本発明は、動物、例えば、牛に塩化マグネシウムを所定量接種又は経口投与することにより、体内に各種ウィルスを生成し、菌のバランスを保ち成牛,仔牛等の健康管理と、ウィルス感染による悪性病気の予防、その他、例えば、成牛の牛乳搾取量の拡大、又は仔牛の成育促進を図る家畜の健康増進方法に関する。
【0002】
【従来の技術】
周知の如く動物の体内に抗体が生成されれば、感染過程とかアレルギー過程から動物を守り得るものであり、抗原物質を注意深く使用していくことによって、任意に免疫とか、抵抗体を導くことができる。これは通常ワクチンとか、アレルギー物質とか、これらに類似するものを使用する。しかし、本発明は、塩化マグネシウムを利用して抗体を生成する方法であり、全く異なる。
【0003】
尚、技術文献としては、次のような文献がある。(1)特公昭51−5045号で動物ワクチンがある。この発明は養鶏のユニーカツスル病の生ワクチン及び養鶏の伝染性コリーザの不活化ワクチンを含有する混合ワクチンで、ユニーカツスル病等の呼吸器系の養鶏の疾病を防止して致死率を下げ得る免疫効果が大いに期待できる処が特徴である。(2)特公昭55−2516号では、牛の尿石症の治療及び予防方法がある。これは各種のマグネシウム塩を牛にマグネシウムに換して0.002〜0.006g/1Kg体重,1日当り経口投与する方法で、通常濃厚飼料の過給と粗飼料の不足に起因する前記の疾病を治療及び予防に役立つとの記述がある。(3)特公昭59−29210号では家畜用マグネシウム固形塩があり、これは食塩にミネラル類,その他栄養剤の配合物と酸化マグネシウム及びこの酸化マグネシウムと反応して複塩を形成する特定の物質を混合して構成するもので、グラステタニー様疾患を防止,治癒することにある。
【0004】
【発明が解決しようとする課題】
前述の如く確かにワクチンの使用によって抗体が生成され、それなりの成果は期待できるがその反面天然抗原の不十分な不活性化により接種動物に不所望な副作用が生じるとともに、この不活性化により天然抗原がある程度変えられ、損失する虞れがあるし、また本来必要とする菌類をも死滅させ、体内の菌のバランスを崩すおそれが多分にある。更に前述の各技術文献は塩化マグネシウムの特異性を単に一面的に捉え、これを疾病の治療,予防等に利用しているにすぎず、本発明が目的とする抗体の生成とか、主として牛の疾病予防,生育環境の向上等とは到底期待できない。
【0005】
【課題を解決するための手段】
請求項1の発明は、家畜、例えば、成牛等の疾病の予防と治癒を図ること、また仔牛の採用日数の拡充、又は成長促進、成育環境の向上を図ること、更には搾乳量の拡充と、品質の向上を図ること、等を意図する。
【0006】
請求項1は、家畜に、1日に体重1kg当たり0.03〜400gの塩化マグネシウムを経口投与することを特徴とした家畜の健康増進方法である。
【0007】
【0008】
【0009】
【0010】
【0011】
【発明の実施の形態】
次に本発明の実施の形態を説明する。
【0012】
(1)乳房症の防止について、
搾乳する前に塩化マグネシウム0.3gの水溶液で乳房及び/又は乳頭を消毒すると、乳房症に極めてかかりにくい。
【0013】
これは、牛乳が牛の体内及び乳房を介して無菌の状態で生成されるために、乳酸菌とかその他一般の雑菌が外部から乳頭を介して侵入する。これによって乳房症にかかると思われる。そこで、塩化マグネシウムで乳房及び/又は乳頭を消毒することによって、この時点で毒性の強くかつ媒介の早い雑菌を死滅させ得るし、また塩化マグネシウムで乳房及び/又は乳頭を消毒することは菌類のバランスを保つことになり、結果として乳房症にはかからないことが判明した。
【0014】
(2)仔牛に塩化マグネシウムを接種又は経口投与した成牛より搾取した牛乳を飲ませることによる抗体の生成についての結果は、次のようになる。
【0015】
先ず、何等処置を施していない、仔牛の体内に、塩化マグネシウムを0.001g/1Kg体重,1日当り接種又は経口投与する。この仔牛は、下痢症状を呈し、その後、一日程度で死滅する。
【0016】
これに対して、成牛の体内に塩化マグネシウムを50g/1Kg体重,1日当り接種又は経口投与して、この成牛から搾取された牛乳を仔牛に飲ませる。それ以後、仔牛の体内に塩化マグネシウムを0.001g/1Kg体重,1日当り接種又は経口投与しても、下痢症状を呈することがないとともに、逆に仔牛の体内にも強い抗体が生成された。従って、この仔牛は風邪に感染することが少なくなること、又はその他の疾病にも極めてかかりにくくなること、等の結果が判明した。
【0017】
【実施例】
以下、本発明の一実施例を説明する。
【0018】
動物にワクチンを接種又は経口投与して発病又は感染させた後、塩化マグネシウムを接種又は経口投与する。この場合塩化マグネシウムの接種又は経口投与は、塩化マグネシウムが動物に含有する水分に対して、その水分に溶ける範囲内とする。例えば、成牛に含有する水分が75%との場合は、塩化マグネシウムは50%は溶けるので略0.03〜400g/1Kg体重を最大とする。尚、体内の塩化マグネシウムは、尿等とともに排泄されるので何ら障害とはならない。
【0019】
“名古屋市緑区”の牛舎の敷地面積、600坪、搾乳牛30頭、育成牛10頭の環境下に於て行った。本発明の実験データを詳細に説明する。
【0020】
下記の表1は、親牛の乳房を、5%の塩化マグネシウム水溶液で消毒し、搾乳した。
【0021】
また飼料への、塩化マグネシウムの添加条件は、b、c、dは、ほぼ30g〜50gの塩化マグネシウムを投与する。但し、cは,出産日の前日より、またdは、また出産日より投与した。
【0022】

Figure 0003788689
【0023】
下記の表2は、何れも出産後、12時間以内に、直接仔牛に塩化マグネシウムを散布し、また出産後、直ちに親牛より隔離し、直接それぞれの添加条件で、仔牛に投与したデータであります。
【0024】
Figure 0003788689
【0025】
以上の結果を資料として、ここで更に究明すると、下記のようなことが、考えられる。
【0026】
第一に、出産後仔牛が、空気や土間に直接触れることによって、そこに発生しているウィルスや他の病原菌に犯された場合には、塩化マグネシウムを、仔牛の体に直接散布する。この結果、この仔牛は、ウィルスや、他の病原菌に犯されることが、少なくなる。
【0027】
此のことは、塩化マグネシウムに、制菌性又は殺菌性があることと、この塩化マグネシウムを散布、投与或いは塩化マグネシウムを含有する乳を、仔牛に投与することにより、キラー細胞の活性化と抗体の生成が確認された。
【0028】
また第二に、親牛の乳房及び乳頭等を、塩化マグネシウムの水溶液内で、浸漬消毒することによっても、死菌ワクチン又は生菌ワクチンの活性化と抗体の生成が確認された。
【0029】
更に第三に、塩化マグネシウムを含有する飼料、換言すれば、抗体合成特性を備えた飼料、仔牛が自発的に、採食することは、仔牛の生体内に、抗体が生成される。
【0030】
次に、下記の表3は、18リットルの水に、塩化マグネシウムを500g添加した水溶液中に、養殖ハマチを泳がして実験したデータを示している。例えば、20分経過した時点で、この養殖ハマチは、口から泡及び血液を放出し、かつ体全体の色が、鮮明となった。
【0031】
以上のようなことを考察するに、塩化マグネシウムが、養殖ハマチの体内に浸透し、生体内に有る抗体が更に活性化し、生体内に有る不良抗体(抗原)を排除しているものであり、その後は素晴らしい成育状況並びに成育環境が生成された状況が確認されている。
【0032】
Figure 0003788689
【0033】
【発明の効果】
請求項1の発明は、家畜に、1日に体重1kg当たり0.03〜400gの塩化マグネシウムを経口投与することを特徴とした家畜の健康増進方法である。従って、家畜、例えば、成牛等の疾病の予防と治癒が図れること、また仔牛の採用日数の拡充、又は成長促進、成育環境の向上が図れること、更には搾乳量の拡充と、品質の向上が図れること、又は体内の菌のバランスを常に維持できること、等の特徴がある。またこれらの特徴は、畜産業者、酪農家等にとっては、誠に有意義である。
【0034】
【0035】[0001]
[Industrial application fields]
The present invention produces various viruses in the body by inoculating or orally administering a predetermined amount of magnesium chloride to animals, for example, cattle, maintaining the balance of the bacteria, and managing the health of adult cattle, calves, etc. The present invention relates to a method for promoting the health of livestock to prevent disease, and for example, to increase milk extraction of adult cattle or promote the growth of calves.
[0002]
[Prior art]
As is well known, if antibodies are generated in the body of an animal, it can protect the animal from infection processes and allergic processes. Careful use of antigenic substances can lead to immunity and resistance arbitrarily. it can. This usually uses a vaccine, an allergen, or something similar. However, the present invention is a method for producing an antibody using magnesium chloride, which is completely different.
[0003]
In addition, there are the following documents as technical documents. (1) There is an animal vaccine in Japanese Patent Publication No. 51-5045. This invention is a mixed vaccine containing live vaccine for chicken poultry Unica sill disease and inactivated vaccine for poultry infectious coryza. It is a feature that can be expected greatly. (2) In Japanese Patent Publication No. 55-2516, there is a method for treating and preventing bovine urolithiasis. This is a method in which various magnesium salts are replaced with magnesium in cattle by 0.002-0.006g / 1Kg body weight, orally administered per day. Usually, the above-mentioned diseases caused by oversupply of concentrated feed and lack of roughage are eliminated. There is a description that it is useful for treatment and prevention. (3) In Japanese Examined Patent Publication No. 59-29210, there is a magnesium salt for livestock, which is a mixture of minerals, other nutrients, magnesium oxide and a specific substance that reacts with magnesium oxide to form a double salt. Is to prevent and cure grasstethany-like diseases.
[0004]
[Problems to be solved by the invention]
As described above, the use of a vaccine will surely produce antibodies, and some results can be expected. However, inadequate inactivation of natural antigens causes undesirable side effects in inoculated animals, and this inactivation causes natural effects. There is a risk that the antigen may be changed to some extent and may be lost, and the fungi originally required may be killed and the balance of the bacteria in the body may be lost. Furthermore, each of the above-mentioned technical documents merely grasps the specificity of magnesium chloride and uses it only for treatment, prevention, etc. of the disease. It cannot be expected to prevent disease and improve the growth environment.
[0005]
[Means for Solving the Problems]
The invention of claim 1 is intended to prevent and cure diseases such as livestock such as adult cattle, expand the number of days employed by calves, promote growth, improve the growth environment, and further increase the milking amount. It is intended to improve quality.
[0006]
Claim 1 is a domestic animal health promotion method characterized by orally administering 0.03-400 g magnesium chloride per kg body weight per day to livestock .
[0007]
[0008]
[0009]
[0010]
[0011]
DETAILED DESCRIPTION OF THE INVENTION
Next, embodiments of the present invention will be described.
[0012]
(1) About prevention of mastopathy
Disinfection of the breast and / or nipple with an aqueous solution of 0.3 g of magnesium chloride before milking makes it very difficult to get mastosis.
[0013]
This is because milk is produced in a sterile state through the body and breast of the cow, so that lactic acid bacteria and other common bacteria enter from the outside through the teat. This seems to cause mastopathy. Thus, disinfecting the breast and / or teat with magnesium chloride can kill the highly toxic and fast-borne bacteria at this point, and disinfecting the breast and / or teat with magnesium chloride is a fungal balance. As a result, it was found that mastosis does not occur.
[0014]
(2) The results of the production of antibodies by feeding milk extracted from adult cows inoculated or orally administered calf with magnesium chloride are as follows.
[0015]
First, 0.001 g / 1 kg body weight of magnesium chloride is inoculated per day or orally administered into the body of a calf that has not been subjected to any treatment. The calf exhibits diarrhea and then dies in about a day.
[0016]
On the other hand, magnesium chloride is inoculated into the body of 50g / 1Kg body weight, orally administered orally per day, and milk extracted from this adult cow is fed to the calf. After that, even when magnesium chloride was inoculated into the calf body at 0.001 g / 1 Kg body weight, daily inoculation or oral administration, diarrhea symptoms were not exhibited, and conversely strong antibodies were produced in the calf body. Accordingly, it has been found that the calf is less likely to be infected with a cold or is extremely less susceptible to other diseases.
[0017]
【Example】
An embodiment of the present invention will be described below.
[0018]
Animals are vaccinated or orally administered to cause disease or infection, and then magnesium chloride is inoculated or administered orally. In this case, inoculation or oral administration of magnesium chloride is within the range in which magnesium chloride is soluble in the water contained in the animal. For example, when the water content in adult cattle is 75%, magnesium chloride dissolves in 50%, so the maximum body weight is about 0.03 to 400 g / 1 Kg. In addition, since magnesium chloride in the body is excreted together with urine and the like, there is no obstacle.
[0019]
It was conducted in the environment of a cow barn area of “Nagoya City Midori Ward”, 600 tsubo, 30 milking cows and 10 breeding cows. The experimental data of the present invention will be described in detail.
[0020]
In Table 1 below, the mother cow's breast was disinfected with 5% magnesium chloride aqueous solution and milked.
[0021]
Moreover, as for the addition conditions of magnesium chloride to feed, b, c, and d administer approximately 30 to 50 g of magnesium chloride. However, c was administered from the day before the date of birth, and d was administered from the date of birth again.
[0022]
Figure 0003788689
[0023]
Table 2 below shows the data that magnesium calf was sprayed directly on calves within 12 hours after delivery, and was isolated from the parent calf immediately after delivery and directly administered to the calves under the respective addition conditions. .
[0024]
Figure 0003788689
[0025]
The following results can be considered when the above results are further investigated here.
[0026]
First, when calves are born and are exposed to direct contact with air or soil and are violated by viruses or other pathogens, magnesium chloride is sprayed directly on the calf body. As a result, the calf is less susceptible to viruses and other pathogens.
[0027]
This means that magnesium chloride has antibacterial or bactericidal properties, and that this magnesium chloride is sprayed, administered, or milk containing magnesium chloride is administered to calves to activate killer cells and antibodies. Generation was confirmed.
[0028]
Secondly, activation of dead vaccine or live vaccine and generation of antibodies were also confirmed by immersing and disinfecting the mother cow's breast and nipple in an aqueous solution of magnesium chloride.
[0029]
Thirdly, a feed containing magnesium chloride, in other words, a feed with antibody synthesis characteristics, and the calf's voluntary feeding, will produce antibodies in the calf's body.
[0030]
Next, Table 3 below shows data obtained by experimenting by swimming cultured bee in an aqueous solution obtained by adding 500 g of magnesium chloride to 18 liters of water. For example, when 20 minutes passed, this cultured hamachi released bubbles and blood from the mouth, and the color of the whole body became clear.
[0031]
In consideration of the above, magnesium chloride penetrates into the body of cultured hamachi, the antibody in the living body is further activated, and the defective antibody (antigen) in the living body is excluded, After that, it has been confirmed that a wonderful growth situation and a growth environment have been created.
[0032]
Figure 0003788689
[0033]
【The invention's effect】
The invention of claim 1 is a domestic animal health promotion method characterized in that 0.03-400 g of magnesium chloride per kg of body weight is orally administered to livestock per day. Therefore, domestic animals, for example, be attained prevention and cure of diseases such as adult cattle, also expanding the adoption days veal, or growth promoting, be attained improvement of growth environment, even the expansion of milk yield, improve quality There are features such as being able to achieve or maintaining the balance of bacteria in the body at all times. In addition, these characteristics are very significant for livestock farmers and dairy farmers.
[0034]
[0035]

Claims (1)

家畜に、1日に体重1kg当たり0.03〜400gの塩化マグネシウムを経口投与することを特徴とした家畜の健康増進方法。A method for promoting the health of livestock, comprising orally administering 0.03-400 g of magnesium chloride per kg of body weight per day to livestock.
JP22827998A 1998-08-12 1998-08-12 Livestock health promotion methods Expired - Fee Related JP3788689B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22827998A JP3788689B2 (en) 1998-08-12 1998-08-12 Livestock health promotion methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22827998A JP3788689B2 (en) 1998-08-12 1998-08-12 Livestock health promotion methods

Publications (2)

Publication Number Publication Date
JP2000063285A JP2000063285A (en) 2000-02-29
JP3788689B2 true JP3788689B2 (en) 2006-06-21

Family

ID=16873997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22827998A Expired - Fee Related JP3788689B2 (en) 1998-08-12 1998-08-12 Livestock health promotion methods

Country Status (1)

Country Link
JP (1) JP3788689B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6275955B2 (en) * 2013-04-25 2018-02-07 松尾 敏郎 Methods for activating cells in organisms other than those who consume magnesium chloride

Also Published As

Publication number Publication date
JP2000063285A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
Saltzburg Federal rules of evidence manual
West Black's veterinary dictionary
JP5216952B2 (en) Feed composition and animal breeding method
Grogan et al. Mare and foal bonding and problems
JP3788689B2 (en) Livestock health promotion methods
Pelzer et al. Zoonotic diseases of cattle
RU2450531C2 (en) Method for enhancement of young farm livestock productiveness
JPS63126830A (en) Method for forming antibody in body of animal and plant
Brown et al. Small Mammals: Self-Assessment Color Review
RU2780858C1 (en) Method for rearing piglets in farms that are disadvantaged in terms of haemophilous polyserositis
Trisunuwati et al. Animal Health and Disease Prevention
Singh Common cattle diseases: Symptoms, treatment and prevention
Barua A REPORT ON FOOT AND MOUTH DISEASE COMPARING ITS MEDICINAL TREATMENT WITH SERUM THERAPY AT RANGUNIA IN CHATTOGRAM, BANGLADESH
Eyarefe et al. Animal health management: principles and practice
Dauda et al. Animal Health
Korinek Notes on Diseases of Swine, Sheep, Poultry and the Dog: Cause, Symptoms and Treatments
Ващенко et al. Animal Diseases
Craig Diseases of swine
Theiler, Arnold & Gray The Veterinary section: Veterinary hygienic principles applicable to stock in South Africa
Roberts Dr. David Roberts' practical home veterinarian
TAPEWORM IBI= RHINOTRACHEITIS.
Seiden RABBITBRUSH= HORSEBRUSH. RABBIT FEVER= TULAREMIA.
Hambidge Fundamentals of Disease and Insect Control
Eichhorn A treatise on veterinary biological therapeutics
Fincher Diseases of Calves

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040608

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040720

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20041130

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041220

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050118

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041221

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20050307

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20050325

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20051207

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20051207

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060323

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090407

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120407

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150407

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees